| Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo (NCT02217033) | South Sound Care Foundation | 2013-01-01 |
| DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer (NCT01763931) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-01-01 |
| Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation (NCT01762020) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-01-01 |
| Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla (NCT02314806) | Hospital General Universitario Elche | 2013-01-01 |
| Intra-operative Digital vs. Standard Mammography (NCT01766102) | Massachusetts General Hospital | 2013-01-01 |
| Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node (NCT01796444) | Shandong Cancer Hospital and Institute | 2013-01-01 |
| SURPASS Retrospective Study (NCT05779982) | Gangnam Severance Hospital | 2013-01-01 |
| The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction (NCT01736605) | Mayo Clinic | 2013-01-01 |
| The PIONEER-01 Study of the Imagio Breast Imaging System (NCT01943916) | Seno Medical Instruments Inc. | 2012-12-21 |
| Classification of Breast Masses Based on Visco-elastic Properties Using SAVE Method (NCT04841252) | Mayo Clinic | 2012-12-19 |
| Preventing Sexual Dysfunction With Aromatase Inhibitors (NCT01603303) | M.D. Anderson Cancer Center | 2012-12-05 |
| A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) (NCT01702558) | Hoffmann-La Roche | 2012-12-03 |
| Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy (NCT01796977) | Halyard Health | 2012-12-01 |
| Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer (NCT01698281) | AEterna Zentaris | 2012-12-01 |
| Tomosynthesis (TS) Versus Ultrasonography (US) in Women With Dense Breast (NCT02066142) | University of Genova | 2012-12-01 |
| A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors (NCT01764087) | Hanmi Pharmaceutical Company Limited | 2012-12-01 |
| Immediate Breast Reconstruction With Acellular Dermal Matrix (NCT04209010) | Aarhus University Hospital | 2012-12-01 |
| Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A) (NCT01699867) | Diagnostic Photonics, Inc. | 2012-12-01 |
| XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer (NCT01777945) | Hoffmann-La Roche | 2012-12-01 |
| Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (NCT02527746) | EVIVE Biotechnology | 2012-12-01 |
| Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer (NCT01763710) | Fundacion Oncosur | 2012-12-01 |
| Exergaming Intervention and Breast Cancer Biomarkers in Black Women (NCT02152462) | Georgetown University | 2012-12-01 |
| Evaluation of Attitudes About Fertility (NCT01705561) | Grupo de Estudios Clínicos Oncológicos Peruano | 2012-12-01 |
| A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment (NCT01702571) | Hoffmann-La Roche | 2012-11-27 |
| Value of Tomosynthesis in Breast Lesion Characterization and Breast Cancer Staging (NCT01881880) | University Hospital, Montpellier | 2012-11-19 |
| Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) (NCT01724606) | Memorial Sloan Kettering Cancer Center | 2012-11-05 |
| Strength Training Study for Survivors of Breast and Gynecologic Cancer (NCT01709175) | Nova Scotia Health Authority | 2012-11-01 |
| Effect of Upper Limb Posture on Limb Volume as Expressed in Circumference Measurement in Healthy Women and in Women With Breast Cancer Related Lymphedema (NCT01672125) | Tel-Aviv Sourasky Medical Center | 2012-11-01 |
| Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab (NCT01479179) | M.D. Anderson Cancer Center | 2012-11-01 |
| A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel (NCT01722968) | Theodoros Foukakis | 2012-11-01 |
| Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer (NCT02001506) | Asan Medical Center | 2012-11-01 |
| Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health (NCT01738152) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. (NCT01745965) | Women's Cancer Study Group GmbH | 2012-11-01 |
| Single Fraction Elderly Breast Irradiation (SiFEBI) (NCT01727011) | Centre Antoine Lacassagne | 2012-11-01 |
| Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer (NCT01840306) | Cancer Trials Ireland | 2012-10-12 |
| Local Treatment by Thermic Destruction of Primitive Breast Cancer (NCT01706016) | Gustave Roussy, Cancer Campus, Grand Paris | 2012-10-09 |
| Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples (NCT01703585) | University Health Network, Toronto | 2012-10-04 |
| Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy. (NCT01723592) | Medical University of Vienna | 2012-10-01 |
| Breast Cup Immobilization Device II (GCC 1047) (NCT01704547) | University of Maryland, Baltimore | 2012-10-01 |
| My Lifestyle Intervention of Food and Exercise (NCT01630499) | University of Florida | 2012-10-01 |
| Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities (NCT01544374) | Icahn School of Medicine at Mount Sinai | 2012-10-01 |
| Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment (NCT02525211) | Institut Paoli-Calmettes | 2012-10-01 |
| Group-based or Individual Information About Disease and Treatment Plan (NCT01699672) | Norwegian University of Science and Technology | 2012-10-01 |
| Tumor Specific Plasma DNA (NCT01617915) | Dartmouth-Hitchcock Medical Center | 2012-10-01 |
| Electronic Patient Reported Symptom Assessment (NCT01833637) | Northwestern University | 2012-10-01 |
| Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy (NCT01789983) | UNC Lineberger Comprehensive Cancer Center | 2012-10-01 |
| Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients (NCT01972984) | Ottawa Hospital Research Institute | 2012-10-01 |
| An Internet-based Weight Loss and Exercise Intervention for Breast Cancer Survivors (NCT01728506) | University of Vermont | 2012-10-01 |
| Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy (NCT01847001) | Columbia University | 2012-10-01 |
| Breast Cancer During Pregnancy (NCT02102282) | Hospital Universitari Vall d'Hebron Research Institute | 2012-10-01 |
| Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer (NCT01698658) | Barbara Ann Karmanos Cancer Institute | 2012-10-01 |
| Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa (NCT01670500) | Beth Israel Deaconess Medical Center | 2012-10-01 |
| 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases. (NCT01927939) | National Taiwan University Hospital | 2012-10-01 |
| Pharmacodynamic Study of BKM120 in Breast Cancer (NCT01513356) | Sofia Perea, Director Clinical Trials Unit. | 2012-10-01 |
| To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy (NCT02549430) | Fondazione Sandro Pitigliani | 2012-10-01 |
| Feasibility Study of Meso BioMatrix Device for Breast Reconstruction (NCT01823107) | Kensey Nash Corporation | 2012-10-01 |
| Effect of Radiation on Tissue for Delayed Breast Reconstruction (NCT01666899) | University of Michigan Rogel Cancer Center | 2012-10-01 |
| Cisplatin + RT for Triple Negative Breast Cancer (NCT01674842) | Dana-Farber Cancer Institute | 2012-10-01 |
| Vitamin D and Mammographic Breast Density (NCT01747720) | CHU de Quebec-Universite Laval | 2012-10-01 |
| The Change Cycle Intervention for Improving Quality of Life in Breast Cancer Survivors (NCT01734499) | Texas Tech University Health Sciences Center | 2012-10-01 |
| Optical Detection of Malignancy During Percutaneous Interventions (NCT01730365) | Philips Healthcare | 2012-10-01 |
| Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy (NCT01727362) | Charite University, Berlin, Germany | 2012-10-01 |
| Imaging Evaluation of the Therapeutic Response of Breast Cancer Bone Metastasis (EMOS) (NCT02900118) | Centre Oscar Lambret | 2012-09-26 |
| Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer (NCT06212908) | University of Sao Paulo | 2012-09-18 |
| Mithramycin for Lung, Esophagus, and Other Chest Cancers (NCT01624090) | National Cancer Institute (NCI) | 2012-09-06 |
| Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy (NCT01649258) | University of Southern California | 2012-09-04 |
| A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision (NCT02923635) | Ain Shams University | 2012-09-01 |
| Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer (NCT01623349) | Dana-Farber Cancer Institute | 2012-09-01 |
| Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours (NCT01795768) | Royal Marsden NHS Foundation Trust | 2012-09-01 |
| Study of Nab-Paclitaxel in High Risk Early Breast Cancer (NCT01690702) | GBG Forschungs GmbH | 2012-09-01 |
| Decision Support Workshop for Breast Reconstruction (NCT01857882) | University Health Network, Toronto | 2012-09-01 |
| Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer (NCT02597179) | Samsung Medical Center | 2012-09-01 |
| Exemestane-RAD001-Metformin (NCT01627067) | M.D. Anderson Cancer Center | 2012-09-01 |
| Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes (NCT01693549) | Hellenic Cooperative Oncology Group | 2012-09-01 |
| Communicating Objective Risk for Personalized Decision Making About Mammography (NCT01686360) | University of Pennsylvania | 2012-09-01 |
| Microwave Ablation of Breast Tumors (NCT04828044) | St. Joseph Hospital of Orange | 2012-09-01 |
| The Effect of Dexmedetomidine of the Immune System (NCT01692210) | M.D. Anderson Cancer Center | 2012-09-01 |
| Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON) (NCT01690325) | Women's Cancer Study Group GmbH | 2012-09-01 |
| Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer (NCT01705691) | NSABP Foundation Inc | 2012-09-01 |
| Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) (NCT01333423) | M.D. Anderson Cancer Center | 2012-09-01 |
| Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction (NCT03106233) | Maastricht University Medical Center | 2012-09-01 |
| Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU (NCT01781299) | University of Pittsburgh | 2012-09-01 |
| Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions (NCT01806558) | Mayo Clinic | 2012-09-01 |
| The Effectiveness of Mindfulness on Chronic Pain in Breast Cancer Survivors (NCT01674881) | University of Aarhus | 2012-09-01 |
| Ovarian Reserve in Premenopausal Breast Cancer (NCT01726322) | Cancer Trials Ireland | 2012-09-01 |
| GRN1005 for Brain Metastases From Breast or Lung Cancer (NCT01679743) | National Cancer Institute (NCI) | 2012-08-29 |
| DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy (NCT01564368) | American College of Radiology Imaging Network | 2012-08-27 |
| Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor (NCT01610284) | Novartis Pharmaceuticals | 2012-08-07 |
| Effects of an Integrative Day-care Clinic Program for Breast Cancer Patients During Chemotherapy (NCT03868865) | Universität Duisburg-Essen | 2012-08-07 |
| Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 (NCT01593020) | M.D. Anderson Cancer Center | 2012-08-03 |
| Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32 (NCT01666171) | Cancer and Leukemia Group B | 2012-08-01 |
| Effects of Electrical Stimulation on Blood Circulation and Sensibility Tactil in Lymphadenectomy (NCT01893957) | University of Sao Paulo | 2012-08-01 |
| A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer (NCT01617668) | Novartis Pharmaceuticals | 2012-08-01 |
| A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation (NCT01572727) | Novartis Pharmaceuticals | 2012-08-01 |
| HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer (NCT02165605) | University of Texas Southwestern Medical Center | 2012-08-01 |
| Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction (NCT01591746) | Mayo Clinic | 2012-08-01 |
| Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast Cancer (NCT01717261) | Maisonneuve-Rosemont Hospital | 2012-08-01 |
| Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast (NCT01659645) | Emory University | 2012-08-01 |
| Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast Cancer (NCT01669252) | SOLTI Breast Cancer Research Group | 2012-08-01 |
| Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors (NCT01627366) | Jonsson Comprehensive Cancer Center | 2012-08-01 |